IMA is loading

Main Financial Data 2016

Main Data: 31/12 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
– total revenues 1,310.85
– industrial gross profit 480.59
– total operating cost 339.25
– operating profit 141.34
– net financial income 6.28
– profit attributable to equity holders of the parent 93.54

 

Consolidated balance sheet Millions / Euro
– working capital 3.42
– non-current assets 446.96
– provision for severance indemnities and other provisions

-80.26

– net debt -99.94
– equity pertaining to the group and minority interests 270.18

 

Other information Millions / Euro
– depreciation, amortization and impairment 39.55
– R & D costs 48.15

 

  Euro
Dividend per share 1.40

 

  No.
Employees 5,109

 

  Euro
Share capital 20,415,200

 

Main Data: 30/06 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 572.2
– gross industrial income  214.7
– total operating cost 169.9
– operating profit 44.8
– net financial income 13.1
– profit attributable to equity holders of the parent 39.4

 

Consolidated balance sheet Millions/Euro
– working capital 41.4
– non-current assets 434.9
– provision for severance indemnities and other provisions -80.8
– net debt -188.9
– equity pertaining to the group and minority interests 206.6

 

Other information Millions/Euro
– depreciation, amortization and impairment 18.3
– R & D costs 23.6

 

  No.
Employees 4,962

 

  Euro
Share capital 20,415,200

 

Net Sales By Sector: Year 2016
  Millions/Euro  
tea, food & other 757.42 57.8%
pharmaceutical 553.43 42.2%
Total 1,310.85 100.0%

 

Net Sales by Country: Year 2016
  Millions/Euro  
E.U. (excluding Italy) 395.45 30.2%
Other European countries 97.33 7.4%
North America 218.69 16.7%
Asia & Middle East 294.65 22.5%
Other countries 128.63 9.8%
Total exports 1,134.75 86.6%
Italy 176.10 13.4%
Total 1,310.85 100.0%